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Obesity and cancer are regarded as two major epidemics of the 21st century.2 It has now been well established that obesity 
is a cause of several cancers, including cancers of the 
colon, post-menopausal breast, uterus, pancreas, gall 
bladder, liver, oesophagus and kidney.2 It has been 
estimated that as many as one-third of all cancers can 
be attributed to an unhealthy diet (such as high caloric 
intake, high intake of red and processed meat and low 
intake of fibre) lack of physical activity and obesity. 
As many as 3% of all the cancers in men and 9% of 
those in women can be attributed directly to obesity.3 
As a result, the World Cancer Research Fund and 
the American Institute of Cancer Research (WCRF/
AICR) have issued guidance on the prevention of 
cancer in the form of 10 recommendations, one of 
them being: “be as lean as possible without becoming 
underweight”.3 
In this issue of SQUMJ, Moten et al. have drawn 
attention to the very important question as to whether 
cancer survivors attempt to lose weight.4 According 
to GLOBOCAN, 14.1 million cancer cases were 
diagnosed in 2012, there were 8.2 million deaths 
and 32.6 million cancer survivors; all these numbers 
were shown to be increasing.5 A cancer survivor is 
defined as an individual with a diagnosis of cancer, 
regardless of the course of illness, until the end of 
his/her life. Epidemiological evidence suggests that 
cancer survivors who are obese and overweight are 
at an increased risk of cancer relapse/progression.3 
Hence, after the diagnosis of cancer, survivors maybe 
interested to learn how they could reduce the chances 
of cancer progression or relapse.6 Clearly, if an 
exposure is associated with developing cancer and if 
that exposure continues, then the risk of subsequent 
cancer progression and/or relapse would be high.6 
The WCRF/AICR recommend that cancer survivors 
follow the recommendations for cancer prevention 
including maintaining a healthy body weight. The 
question then arises—is there clear evidence that 
achieving and maintaining a lean body mass actually 
leads to a reduction in the incidence of cancer?
Although there is no evidence in the form of phase 
III studies, epidemiological evidence is strong. Robust 
data have emerged to suggest that the control of obesity 
and related lifestyle factors leads to the prevention of 
cancer. The European Prospective Investigation into 
Cancer and Nutrition (EPIC) study7 and the VITamins 
And Life-style (VITAL) study8 are large prospective 
studies that have addressed the question. Lifestyle 
modifications, including a reduction in body weight, 
actually lead to a reduction in the incidence of and 
mortality from cancer.9,10 More recently, a scientific 
rationale for this connection has begun to emerge 
as the biological mechanisms which suggest that 
obesity is a cause of cancer are beginning to be better 
understood.11
Fat tissue is now considered to be an endocrine 
organ, which secretes adipokines, mainly leptin. 
Leptin induces the upregulation of transcription 
factors through activation of PI3K, MAPK and STAT3 
pathways. Pro-inflammatory cytokines, such as 
TNF-α, IL-2 and IL-10 (secreted by the adipose tissue)
lead to the activation of transcription factor NF-ĸB. 
Adipose tissue also produces steroid hormones, such 
as oestrogens, progesterone and androgens; these 
are pro-inflammatory and lead to the activation of 
various transcription factors. Importantly, insulin 
and insulin-like growth factor 1 (IGF-1) which are 
elevated in people with obesity, signal through the 
Akt/PI3K/mTOR pathway, which in turn leads to 
the release of leptin and inflammatory cytokines 
[Figure 1].11
As a result of the combined secretion of adipokines, 
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pro-inflammatory cytokines, steroid hormones, a 
state of persistent hyperinsulinemia, and the resultant 
continuous upregulation of transcription factors, 
the risk of cancer progression or its recurrence are 
higher amongst obese cancer survivors. Furthermore, 
cancer survivors have an increased risk of morbidity 
and mortality, not only from cancer, but also from 
competing factors, such as heart disease, and 
psychological disturbances [Figure 2].11
Not only is the risk of recurrence and the 
morbidity and mortality higher among obese patients, 
but obesity also poses significant challenges in cases 
where subsequent treatment is needed. The challenges 
are present right through the stages of diagnosis and 
surgical and medical management, and even when 
trying to maintain good pain control. One of the 
surgeon’s nightmares is to operate on an obese patient. 
Based on the concept that the aim of cancer surgery 
is to perform a radical excision, the accessibility of 
organs and the technicality of procedures for an 
obese patient present a major challenge for the course 
of the surgery. Specific procedures like pelvic and 
para-aortic lymph node dissection are sometimes 
omitted which compromise the process of optimal 
treatment. Post-operative complications such as ulnar 
neuropathy, deep vein thrombosis, right ventricular 
failure, atrial dysrhythmia and aspiration pneumonia 
are more frequent in obese patients.12,13 Obese patients 
also present challenges to the anaesthesiologist 
while the pharmacokinetics of most drugs and the 
responses to some medications are altered by obesity. 
Chemotherapy can therefore be under- or over-
prescribed for obese patients. 
Another question then arises, what can be done to 
curb obesity and its attendant complications in cancer 
survivors? The American Society of Clinical Oncology 
(ASCO) has published guidance for cancer survivors 
on weight reduction strategies.14 While the main focus 
is still on ‘lifestyle modifications’, other strategies, 
such as weight loss drugs and bariatric surgery, are 
indicated for a selected few; however, the long term 
consequences of these treatments are not known. 
Cancer survivors in Moten et al.’s study did not 
demonstrate greater effort to lose weight compared 
to people with no history of cancer. This was despite 
having been through the ordeal of the diagnosis of 
cancer and the subsequent treatment.4 Why? Is it 
because of a lack of awareness and motivation amongst 
the survivors, or is it because the task is overwhelming 
and they feel it is too late to remedy the situation? The 
answer is probably all of the above. The authors of this 
editorial believe that just conducting a ‘fire-fighting 
campaign’ to treat obesity after the diagnosis of cancer 
may not be effective. The seeds of obesity are laid in 
childhood, or even before, and that is why obesity is 
turning into one of the epidemics of the 21st century.15 
For example, it has been suggested that environmental 
influences during physical development increase the 
susceptibility to both obesity and cancer in adulthood 
by reprogramming of the epigenome.16 This is perhaps 
one of the many reasons that up to one-third of the 
children in developed countries such as the USA, and 
one-fifth of those in developing countries, like Oman 
are obese—and the incidence is on the rise.17
This epidemic is assuming alarming proportions, 
especially since obesity can cause cancer in the first 
place, as well as increasing the risk of subsequent 
cancers in survivors. There is no simple remedy. 
Serious efforts are required to modify not just 
individual lifestyles, but the overall environment to 
make it easier for individuals to make healthy choices 
in terms of food and physical activity. The provision of 
Figure 1: Biological explanation of increased risk of 
cancer amongst obese patients. Figure 2: Subsequent risks amongst cancer survivors.
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healthy food in schools, offices and eating places, the 
availability of walking and cycling tracks and facilities 
for regular exercise, in addition to time allocation for 
physical activities during school and work, are only 
a few suggestions which can create an environment 
conducive to a healthy lifestyle and curb the dual 
menace of obesity and cancer. Everybody should play 
a part—parents, curriculum designers, the media, the 
food industry, members of civil society, politicians and 
policy makers. 
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